Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
A startup will sift through “treasure troves” of data from failed trials to find abandoned Alzheimer’s drugs that might work for some patients.
In an experimental trial, surgeons have implanted deep-brain stimulators into U.S. and Canadian Alzheimer’s patients.
When he learned in 1995 that he had Alzheimer’s disease, William Utermohlen, an American artist living in London, immediately began work on an ambitious series of self-portraits.
Researchers hope that radio transmitters can warn of cognitive decline earlier.
Enhancing neuron gene expression may improve memory.
Compounds that trigger the growth of new brain cells might help treat depression.
A blood test that identifies the disorder in its early stages could soon be made available to researchers.
Electrodes implanted in the brain show promise in early trials.
Gene probes deployed in eyedrops show brain damage in MRIs of mice.